About Stemrx Bioscience Solutions Private Limited
Data last updated:
Stemrx Bioscience Solutions Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 13 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U93030MH2014PTC253238. Its GSTIN is 27AAUCS3062R1ZD (Maharashtra).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.28 Lakh. It is led by directors including Neetin Shivajirao Desai and Pradeep Venkatrao Mahajan.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.63 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹50.83 Lakh (net margin 3.7%) and EBITDA of ₹2.03 Cr (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 10% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 4 brands: Stemrx Biosciences, OrbisX, Stemrx Bioscience and Vrozart Health. As per MCA filings, the company has open charges of ₹20 Lakh on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Fermbox Bio Private Limited.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stemrx.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressFirst Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Stemrx Bioscience Solutions Private Limited
The main business activity of Stemrx Bioscience Solutions is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stemrx Bioscience Solutions Private Limited FY 2025 filings available
Stemrx Bioscience Solutions Private Limited reported revenue of ₹13.63 Cr (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Stemrx Bioscience Solutions Private Limited
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stemrx Bioscience Solutions Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.03 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹50.83 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stemrx Bioscience Solutions Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stemrx Bioscience Solutions are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fermbox Bio Private Limited | •••• | •••• | •••• | •••• | 18 | Anekal, Karnataka, India |
| Biotech Desk Private Limited | •••• | •••• | •••• | •••• | 23 | Hyderabad, Telangana, India |
| Vizen Life Sciences Private Limited | •••• | •••• | •••• | •••• | 159 | Hyderabad, Telangana, India |
| L.J. International Limited | •••• | •••• | •••• | •••• | - | Cochin, Kerala, India |
| Immunetic Lifesciences Private Limited | •••• | •••• | •••• | •••• | 39 | New Delhi, Delhi, India |
| Stemrx Bioscience Solutions Private Limited this company | •••• | •••• | •••• | •••• | - | Navi Mumbai, Maharashtra, India |
| Levim Biotech LLP | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Beej Sheetal Research Private Limited | •••• | •••• | •••• | •••• | 10 | Jalna, Maharashtra, India |
| Spinco Biotech Private Limited | •••• | •••• | •••• | •••• | 13 | Chennai, Tamil Nadu, India |
| Kaypeeyes Biotech Private Limited | •••• | •••• | •••• | •••• | - | Mysore., Karnataka, India |
| Jubilant Therapeutics India Limited | •••• | •••• | •••• | •••• | - | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Stemrx Bioscience Solutions by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited is audited by MANOJ H JAISWAL for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MANOJ H JAISWAL | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neetin Shivajirao Desai | Director | 13 Feb 2014 | 12 Years 7 Months | Current |
| Pradeep Venkatrao Mahajan | Director | 13 Feb 2014 | 12 Years 7 Months | Current |
| Vipula Pradeep Mahajan | Director | 13 Feb 2014 | 12 Years 7 Months | Current |
Ownership and Shareholding of Stemrx Bioscience Solutions Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stemrx Bioscience Solutions Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2015 | Idbi Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Deals & Funding of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Funding round | ₹2 Cr | Investors: Birthstone Capital |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions operates multiple associated brands including Stemrx Biosciences, OrbisX, and Stemrx Bioscience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| StemRx Biosciences develops regenerative medicine and sells herbal supplements online. | stemrxbiosciences.in | |
| CRM software for automotive detailers and tinters to manage bookings, inventory, and communications. | orbisx.com | |
| Regenerative medicine and nutraceutical supplements in India. | stemrxbiosciences.com | |
| Provider of medical tourism services | vrozarthealth.com |
Employees and EPFO Compliance at Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited has a workforce of 7 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Aken Jatin Sanghavi ceased to be Additional Director on 18 Nov 2022.
Credit Ratings, Litigation & Regulatory Alerts for Stemrx Bioscience Solutions Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stemrx Bioscience Solutions Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stemrx Bioscience Solutions Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAUCS3062R1ZD | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stemrx Bioscience Solutions Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U93030MH2014PTC253238.
Stemrx Bioscience Solutions reported revenue of ₹13.63 Cr for FY 2025 (down 17% YoY).
Stemrx Bioscience Solutions has 3 current directors:
- Neetin Shivajirao Desai - Director
- Pradeep Venkatrao Mahajan - Director
- Vipula Pradeep Mahajan - Director
Stemrx Bioscience Solutions reported a net profit of ₹50.83 Lakh (net margin 3.7%) and EBITDA of ₹2.03 Cr (EBITDA margin 14.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stemrx Bioscience Solutions is 37% over three years and 10% over five years. In the latest year (FY 2025) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Stemrx Bioscience Solutions is 27AAUCS3062R1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Stemrx Bioscience Solutions is U93030MH2014PTC253238. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stemrx Bioscience Solutions was incorporated on 13 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Stemrx Bioscience Solutions has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.
The peers of Stemrx Bioscience Solutions by revenue are Fermbox Bio Private Limited, Biotech Desk Private Limited, Vizen Life Sciences Private Limited, L.J. International Limited, Immunetic Lifesciences Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Aken Jatin Sanghavi ceased to be Additional Director on 18 Nov 2022. Siddhant Pradeep Mahajan ceased to be Director on 18 Oct 2021. Vijay Gopal Pandhare ceased to be Director on 03 Sep 2015. Stemrx Bioscience Solutions has 6 board changes on record in total.